LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91,163 | -61.6% | 83,635 | -19.3% | 0.00% | – |
| Q2 2023 | $237,626 | +225.4% | 103,581 | +244.6% | 0.00% | – |
| Q1 2023 | $73,036 | +43.5% | 30,056 | +12.8% | 0.00% | – |
| Q4 2022 | $50,907 | -20.5% | 26,653 | 0.0% | 0.00% | – |
| Q3 2022 | $64,000 | +82.9% | 26,653 | +41.4% | 0.00% | – |
| Q2 2022 | $35,000 | -5.4% | 18,848 | +7.3% | 0.00% | – |
| Q1 2022 | $37,000 | -46.4% | 17,566 | 0.0% | 0.00% | – |
| Q4 2021 | $69,000 | -17.9% | 17,566 | 0.0% | 0.00% | – |
| Q3 2021 | $84,000 | +200.0% | 17,566 | +185.4% | 0.00% | – |
| Q2 2021 | $28,000 | -12.5% | 6,154 | +12.8% | 0.00% | – |
| Q1 2021 | $32,000 | +88.2% | 5,458 | +8.3% | 0.00% | – |
| Q4 2020 | $17,000 | +142.9% | 5,041 | 0.0% | 0.00% | – |
| Q3 2020 | $7,000 | -50.0% | 5,041 | -27.2% | 0.00% | – |
| Q2 2020 | $14,000 | -6.7% | 6,928 | -6.3% | 0.00% | – |
| Q1 2020 | $15,000 | -78.9% | 7,393 | -56.6% | 0.00% | – |
| Q4 2019 | $71,000 | +54.3% | 17,015 | +9.5% | 0.00% | – |
| Q3 2019 | $46,000 | -53.1% | 15,545 | 0.0% | 0.00% | – |
| Q2 2019 | $98,000 | +12.6% | 15,545 | 0.0% | 0.00% | – |
| Q1 2019 | $87,000 | -15.5% | 15,545 | 0.0% | 0.00% | – |
| Q4 2018 | $103,000 | -34.4% | 15,545 | +5.9% | 0.00% | – |
| Q3 2018 | $157,000 | -10.8% | 14,680 | 0.0% | 0.00% | – |
| Q2 2018 | $176,000 | +29.4% | 14,680 | -7.6% | 0.00% | – |
| Q1 2018 | $136,000 | -31.0% | 15,889 | -19.3% | 0.00% | – |
| Q4 2017 | $197,000 | -18.6% | 19,699 | 0.0% | 0.00% | – |
| Q3 2017 | $242,000 | -20.7% | 19,699 | +6.1% | 0.00% | – |
| Q2 2017 | $305,000 | +17.8% | 18,570 | +2.6% | 0.00% | – |
| Q1 2017 | $259,000 | +2.8% | 18,105 | -0.7% | 0.00% | – |
| Q4 2016 | $252,000 | +49.1% | 18,239 | +94.6% | 0.00% | – |
| Q3 2016 | $169,000 | +17.4% | 9,372 | -7.7% | 0.00% | – |
| Q2 2016 | $144,000 | +17.1% | 10,149 | 0.0% | 0.00% | – |
| Q1 2016 | $123,000 | -8.9% | 10,149 | 0.0% | 0.00% | – |
| Q4 2015 | $135,000 | +27.4% | 10,149 | 0.0% | 0.00% | – |
| Q3 2015 | $106,000 | +100.0% | 10,149 | +52.5% | 0.00% | – |
| Q2 2015 | $53,000 | – | 6,654 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |